Parathyroid adenoma epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(Created page with "__NOTOC__ {{Parathyroid adenoma}} {{CMG}}; {{AE}} ==Overview== ==Epidemiology and Demographics== ===Incidence=== *The incidence/prevalence of [disease name] is approximatel...")
 
Line 6: Line 6:


==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Incidence===
* A single parathyroid adenoma is responsible for 80% to 85% of hyperparathyroidism<ref name="pmid29022783">{{cite journal |vauthors=Edafe O, Collins EE, Ubhi CS, Balasubramanian SP |title=Current predictive models do not accurately differentiate between single and multi gland disease in primary hyperparathyroidism: a retrospective cohort study of two endocrine surgery units |journal=Ann R Coll Surg Engl |volume=100 |issue=2 |pages=140–145 |date=February 2018 |pmid=29022783 |pmc=5838681 |doi=10.1308/rcsann.2017.0112 |url=}}</ref>.
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
* A double adenomas the culprit in 4% to 5%, and parathyroid hyperplasia in 10% to 12%<ref name="pmid29939647">{{cite journal |vauthors=Wolfe SA, Sharma S |title= |journal= |volume= |issue= |pages= |date= |pmid=29939647 |doi= |url=}}</ref>.  
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
* Parathyroid carcinomas are very rare causes of hyperparathyroidism and account for less than 1% of disease.  
 
* Adenomas are most common in patients 50 to 70 years old.
===Prevalence===
* They can occur at any age. Women are affected 3-times as often as men.
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
 
===Case-fatality rate/Mortality rate===
*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
*The case-fatality rate/mortality rate of [disease name] is approximately [number range].
 
===Age===
*Patients of all age groups may develop [disease name].
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
*[Disease name] commonly affects individuals younger than/older than [number of years] years of age.
*[Chronic disease name] is usually first diagnosed among [age group].
*[Acute disease name] commonly affects [age group].
 
===Race===
*There is no racial predilection to [disease name].
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
===Gender===
*[Disease name] affects men and women equally.
*[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
 
===Region===
*The majority of [disease name] cases are reported in [geographical region].
 
*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
 
===Developed Countries===
 
===Developing Countries===


==References==
==References==

Revision as of 12:07, 30 September 2019

Parathyroid adenoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Parathyroid Adenoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Parathyroid adenoma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Parathyroid adenoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Parathyroid adenoma epidemiology and demographics

CDC on Parathyroid adenoma epidemiology and demographics

Parathyroid adenoma epidemiology and demographics in the news

Blogs on Parathyroid adenoma epidemiology and demographics

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Parathyroid adenoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Epidemiology and Demographics

  • A single parathyroid adenoma is responsible for 80% to 85% of hyperparathyroidism[1].
  • A double adenomas the culprit in 4% to 5%, and parathyroid hyperplasia in 10% to 12%[2].
  • Parathyroid carcinomas are very rare causes of hyperparathyroidism and account for less than 1% of disease.
  • Adenomas are most common in patients 50 to 70 years old.
  • They can occur at any age. Women are affected 3-times as often as men.

References

  1. ↑ Edafe O, Collins EE, Ubhi CS, Balasubramanian SP (February 2018). "Current predictive models do not accurately differentiate between single and multi gland disease in primary hyperparathyroidism: a retrospective cohort study of two endocrine surgery units". Ann R Coll Surg Engl. 100 (2): 140–145. doi:10.1308/rcsann.2017.0112. PMC 5838681. PMID 29022783.
  2. ↑ Wolfe SA, Sharma S. PMID 29939647. Missing or empty |title= (help)

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Parathyroid_adenoma_epidemiology_and_demographics&oldid=1582931"